Dartmouth Cancer Center, affiliated with Dartmouth Health and the Geisel School of Medicine at Dartmouth, was named in Becker’s Hospital Review’s 2024 list of hospitals and health systems recognized for excellence in oncology. The list highlights over 100 institutions with oncology programs driving innovation, research and discovery, and includes other leading medical organizations like Memorial Sloan Kettering Cancer Center, Cleveland Clinic, Dana-Farber Cancer Institute and Johns Hopkins.
The hospitals and health systems featured are among the top-ranked providers of cancer care nationally, where their oncology programs offer advanced treatment options, conduct meaningful research, participate in forward-thinking clinical trials and abide by safety regulations.
Patients have consistently ranked Dartmouth Cancer Center in the top 5% of healthcare organizations nationwide in delivering exceptional experience, thus earning the Press Ganey Human Experience Pinnacle of Excellence Award for four consecutive years. This distinction reflects the Center’s commitment to comprehensive, patient-centered cancer care through an interdisciplinary approach, involving a team of specialists who tailor treatment plans to each patient’s needs.
Dartmouth Cancer Center, one of only 57 National Cancer Institute-designated Comprehensive Cancer Centers in the United States, integrates cutting-edge research and clinical trials across a broad spectrum of cancers, from blood cancers to pediatric oncology. Its research programs focus on cancer biology, population science, immunotherapy and translational engineering, which bridge scientific discoveries with clinical practice. With its renowned research and clinical infrastructures, the Center offers patients access to the latest treatments and innovations.
The Becker’s editorial team accepted nominations for this list, and also took into consideration rankings from reputable organizations such as U.S. News & World Report and Newsweek. The list is meant to honor oncology programs that are at the top of their field.
Read the full list of hospitals and health systems awarded here.
About Dartmouth Cancer Center
Since 1972, Dartmouth Cancer Center (DCC) has combined groundbreaking and advanced cancer research at Dartmouth and the Geisel School of Medicine with award-winning, personalized, compassionate, patient-centered cancer care and clinical trials. At its flagship location at Dartmouth Health’s Dartmouth Hitchcock Medical Center, with 14 locations across New Hampshire and Vermont, DCC is one of fewer than 60 National Cancer Institute-designated Comprehensive Cancer Centers nationally. Each year, DCC manages 74,000 appointments, treats more than 4,500 newly diagnosed patients, and currently offers more than 240 active clinical trials. DCC remains committed to excellence, outreach and education. DCC strives to create new knowledge and impact, accelerate integrated and collaborative research to prevent and cure cancer, enhance survivorship and promote cancer-related health equity. Learn more at cancer.dartmouth.edu.